Gengtai Ye

1838 North Guangzhou Avenue
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

ELFN2 inhibits YAP-driven lymph node metastasis in gastric cancer by blocking PP1A-mediated dephosphorylation.

ELFN2 inhibits YAP-driven lymph node metastasis in gastric cancer by blocking PP1A-mediated dephosphorylation.

Journal: Experimental cell research

Published: December 12, 2025

Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer.

Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer.

Journal: International journal of biological sciences

Published: March 06, 2025

UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer.

UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer.

Journal: Communications biology

Published: January 14, 2025

Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.

Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.

Journal: Experimental & molecular medicine

Published: July 28, 2023

N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.

N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 09, 2023

Landscape of exitrons in gastric cancer.

Landscape of exitrons in gastric cancer.

Journal: EBioMedicine

Published: June 02, 2022

Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer.

Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer.

Journal: Journal of translational medicine

Published: May 24, 2022

Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer.

Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer.

Journal: Molecular therapy oncolytics

Published: July 08, 2021

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells.

CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells.

Journal: Journal of translational medicine

Published: January 28, 2021

Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.

Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.

Journal: Theranostics

Published: March 14, 2020

Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.

Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.

Journal: Clinical epigenetics

Published: February 24, 2020

CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer.

CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer.

Journal: Cell death & disease

Published: October 29, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026